financetom
Business
financetom
/
Business
/
In pictures: Bollywood’s top grossing films of 2019
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
In pictures: Bollywood’s top grossing films of 2019
Sep 2, 2019 6:33 AM

In pictures: Bollywood’s top grossing films of 2019

SUMMARY

Prabhas and Shraddha Kapoor starrer Sahoo hit the screens on Friday and is now eyeing Rs 300 crore mark after grossing Rs 200 crore at the box office in its first three days of release, across Hindi, Tamil, and Telugu versions. This year so far, Bollywood has witnessed several hits from Uri: The Surgical Strike to Mission Mangal. However,there were many disappointments from the world's most prolific film industry. Here are some of the top grossing Bollywood films this year (Collection source: Bollywood Hungama):

By Kanishka Gupta Sept 3, 2019 4:01:31 PM IST (Updated)

Uri: The Surgical Strike. Release date: January 11; Budget: Rs 25 crore; Box office collection: Rs 342.06 crore

Kabir Singh. Release date: June 21; Budget: Rs 68 crore; Box office collection: Rs 372.3 crore

Bharat. Release date: June 5; Budget: Rs 100 crore; Box office collection: Rs 314.68 crore

Gully Boy. Release date: February 14; Budget: Rs 84 crore; Box office collection: Rs 238.16 crore

Kesari. Release date: March 21; Budget: Rs 80 crore; Box office collection: Rs 207.09 crore

Super 30. Release date: July 12; Budget: Rs 115 crore; Box office collection: Rs 208.9 crore

Badla. Release date: March 8; Budget: Rs 10 crore; Box office collection: Rs 138.49 crore

Luka Chuppi. Release date: March 1; Budget: Rs 25 crore; Box office collection: Rs 128.86 crore

Mission Mangal. Release date: August 15; Budget: Rs 32 crore; Box office collection: Rs 261.86 crore

De De Pyaar De. Release date: May 16; Budget: Rs 75 crore; Box office collection: Rs 138.51 crore

Total Dhamaal. Release date: February 22; Budget: Rs 113 crore; Box office collection: Rs 228.27 crore

Batla House. Release date: August 15, 2019; Budget: Rs 47 crore; Box office collection: Rs 121.49 crore

Sonchiriya. Release date: March 1; Budget: Rs 30 crore; Box office collection: Rs 6.60 crore

Why Cheat India. Release date: January 18;Budget: Rs 20 crore;Box office collection: Rs 8.6 crore

Kalank. Release date: April 17; Budget: Rs 150 crore; Box office collection: Rs 145.62 crore

Student of the Year 2. Release date: May 10; Budget: Rs 80 crore; Box office collection: Rs 97.81 crore

India's Most Wanted. Release date: May 24; Budget: Rs 37 crore; Box office collection: Rs 15.42 crore

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US regional banks capitalize on rising deal fees to counter high deposit costs
US regional banks capitalize on rising deal fees to counter high deposit costs
Oct 17, 2024
(Reuters) - U.S. regional banks' profits outdid Wall Street expectations in the third quarter as their investment banking fees surged from a revival in dealmaking and helped offset higher deposit costs.  Underwriting and M&A activity picked up pace, taking advantage of a stock market rally and leaning on a combination of economic resilience and hopes of more cuts in interest...
US awards contracts for making higher enriched uranium for new reactors
US awards contracts for making higher enriched uranium for new reactors
Oct 17, 2024
WASHINGTON, Oct 17 (Reuters) - The U.S. rolled out initial contracts to four companies hoping to produce a new, more highly enriched uranium fuel for an expected wave of high-tech reactors, the U.S. Energy Department said on Thursday. Russia is currently the only country that makes the fuel called high-assay low-enriched uranium fuel, or HALEU, in commercial volumes. Funds to...
Merck's RSV antibody for infants shows over 60% efficacy in mid-late-stage study
Merck's RSV antibody for infants shows over 60% efficacy in mid-late-stage study
Oct 17, 2024
Oct 17 (Reuters) - Merck ( MRK ) said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing respiratory syncytial virus (RSV) infections in infants. The seasonal shot met its primary goal in the mid-to-late stage trial, reducing the incidence of lower respiratory tract infections in healthy infants up to one year of age entering their...
Supernus Pharmaceuticals Reports 'Promising' Data in Trial of Anti-Depression Drug Candidate
Supernus Pharmaceuticals Reports 'Promising' Data in Trial of Anti-Depression Drug Candidate
Oct 17, 2024
06:01 PM EDT, 10/17/2024 (MT Newswires) -- Supernus Pharmaceuticals ( SUPN ) said late Thursday the phase 2a open-label study of SPN-820 in adults with major depressive disorder yielded promising data. The company said the study evaluated the safety and tolerability of a 2400 mg dose of the investigational drug given once every three days as an adjunctive treatment to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved